11:54:33,240 graphrag.config.read_dotenv INFO Loading pipeline .env file
11:54:33,262 graphrag.index.cli INFO using default configuration: {
    "llm": {
        "api_key": "REDACTED, length 56",
        "type": "openai_chat",
        "model": "llama3-8b-8192",
        "max_tokens": 3000,
        "request_timeout": 300.0,
        "api_base": "https://api.groq.com/openai/v1",
        "api_version": null,
        "proxy": null,
        "cognitive_services_endpoint": null,
        "deployment_name": null,
        "model_supports_json": true,
        "tokens_per_minute": 0,
        "requests_per_minute": 0,
        "max_retries": 5,
        "max_retry_wait": 20.0,
        "sleep_on_rate_limit_recommendation": true,
        "concurrent_requests": 5
    },
    "parallelization": {
        "stagger": 0.5,
        "num_threads": 50
    },
    "async_mode": "threaded",
    "root_dir": ".",
    "reporting": {
        "type": "file",
        "base_dir": "output/${timestamp}/reports",
        "storage_account_blob_url": null
    },
    "storage": {
        "type": "file",
        "base_dir": "output/${timestamp}/artifacts",
        "storage_account_blob_url": null
    },
    "cache": {
        "type": "file",
        "base_dir": "cache",
        "storage_account_blob_url": null
    },
    "input": {
        "type": "file",
        "file_type": "text",
        "base_dir": "input",
        "storage_account_blob_url": null,
        "encoding": "utf-8",
        "file_pattern": ".*\\.txt$",
        "file_filter": null,
        "source_column": null,
        "timestamp_column": null,
        "timestamp_format": null,
        "text_column": "text",
        "title_column": null,
        "document_attribute_columns": []
    },
    "embed_graph": {
        "enabled": false,
        "num_walks": 10,
        "walk_length": 40,
        "window_size": 2,
        "iterations": 3,
        "random_seed": 597832,
        "strategy": null
    },
    "embeddings": {
        "llm": {
            "api_key": "REDACTED, length 56",
            "type": "openai_embedding",
            "model": "nomic-ai/nomic-embed-text-v1.5-GGUF/nomic-embed-text-v1.5.Q2_K.gguf",
            "max_tokens": 4000,
            "request_timeout": 180.0,
            "api_base": "http://localhost:1234/v1",
            "api_version": null,
            "proxy": null,
            "cognitive_services_endpoint": null,
            "deployment_name": null,
            "model_supports_json": null,
            "tokens_per_minute": 0,
            "requests_per_minute": 0,
            "max_retries": 10,
            "max_retry_wait": 20.0,
            "sleep_on_rate_limit_recommendation": true,
            "concurrent_requests": 5
        },
        "parallelization": {
            "stagger": 0.5,
            "num_threads": 50
        },
        "async_mode": "threaded",
        "batch_size": 16,
        "batch_max_tokens": 8191,
        "target": "required",
        "skip": [],
        "vector_store": null,
        "strategy": null
    },
    "chunks": {
        "size": 300,
        "overlap": 100,
        "group_by_columns": [
            "id"
        ],
        "strategy": null
    },
    "snapshots": {
        "graphml": false,
        "raw_entities": false,
        "top_level_nodes": false
    },
    "entity_extraction": {
        "llm": {
            "api_key": "REDACTED, length 56",
            "type": "openai_chat",
            "model": "llama3-8b-8192",
            "max_tokens": 3000,
            "request_timeout": 300.0,
            "api_base": "https://api.groq.com/openai/v1",
            "api_version": null,
            "proxy": null,
            "cognitive_services_endpoint": null,
            "deployment_name": null,
            "model_supports_json": true,
            "tokens_per_minute": 0,
            "requests_per_minute": 0,
            "max_retries": 5,
            "max_retry_wait": 20.0,
            "sleep_on_rate_limit_recommendation": true,
            "concurrent_requests": 5
        },
        "parallelization": {
            "stagger": 0.5,
            "num_threads": 50
        },
        "async_mode": "threaded",
        "prompt": "prompts/entity_extraction.txt",
        "entity_types": [
            "organization",
            "person",
            "geo",
            "event"
        ],
        "max_gleanings": 0,
        "strategy": null
    },
    "summarize_descriptions": {
        "llm": {
            "api_key": "REDACTED, length 56",
            "type": "openai_chat",
            "model": "llama3-8b-8192",
            "max_tokens": 3000,
            "request_timeout": 300.0,
            "api_base": "https://api.groq.com/openai/v1",
            "api_version": null,
            "proxy": null,
            "cognitive_services_endpoint": null,
            "deployment_name": null,
            "model_supports_json": true,
            "tokens_per_minute": 0,
            "requests_per_minute": 0,
            "max_retries": 5,
            "max_retry_wait": 20.0,
            "sleep_on_rate_limit_recommendation": true,
            "concurrent_requests": 5
        },
        "parallelization": {
            "stagger": 0.5,
            "num_threads": 50
        },
        "async_mode": "threaded",
        "prompt": "prompts/summarize_descriptions.txt",
        "max_length": 500,
        "strategy": null
    },
    "community_reports": {
        "llm": {
            "api_key": "REDACTED, length 56",
            "type": "openai_chat",
            "model": "llama3-8b-8192",
            "max_tokens": 3000,
            "request_timeout": 300.0,
            "api_base": "https://api.groq.com/openai/v1",
            "api_version": null,
            "proxy": null,
            "cognitive_services_endpoint": null,
            "deployment_name": null,
            "model_supports_json": true,
            "tokens_per_minute": 0,
            "requests_per_minute": 0,
            "max_retries": 5,
            "max_retry_wait": 20.0,
            "sleep_on_rate_limit_recommendation": true,
            "concurrent_requests": 5
        },
        "parallelization": {
            "stagger": 0.5,
            "num_threads": 50
        },
        "async_mode": "threaded",
        "prompt": null,
        "max_length": 2000,
        "max_input_length": 8000,
        "strategy": null
    },
    "claim_extraction": {
        "llm": {
            "api_key": "REDACTED, length 56",
            "type": "openai_chat",
            "model": "llama3-8b-8192",
            "max_tokens": 3000,
            "request_timeout": 300.0,
            "api_base": "https://api.groq.com/openai/v1",
            "api_version": null,
            "proxy": null,
            "cognitive_services_endpoint": null,
            "deployment_name": null,
            "model_supports_json": true,
            "tokens_per_minute": 0,
            "requests_per_minute": 0,
            "max_retries": 5,
            "max_retry_wait": 20.0,
            "sleep_on_rate_limit_recommendation": true,
            "concurrent_requests": 5
        },
        "parallelization": {
            "stagger": 0.5,
            "num_threads": 50
        },
        "async_mode": "threaded",
        "enabled": false,
        "prompt": "prompts/claim_extraction.txt",
        "description": "Any claims or facts that could be relevant to information discovery.",
        "max_gleanings": 0,
        "strategy": null
    },
    "cluster_graph": {
        "max_cluster_size": 10,
        "strategy": null
    },
    "umap": {
        "enabled": false
    },
    "local_search": {
        "text_unit_prop": 0.5,
        "community_prop": 0.1,
        "conversation_history_max_turns": 5,
        "top_k_entities": 10,
        "top_k_relationships": 10,
        "max_tokens": 12000,
        "llm_max_tokens": 2000
    },
    "global_search": {
        "max_tokens": 3000,
        "data_max_tokens": 12000,
        "map_max_tokens": 1000,
        "reduce_max_tokens": 2000,
        "concurrency": 32
    },
    "encoding_model": "cl100k_base",
    "skip_workflows": []
}
11:54:33,269 graphrag.index.create_pipeline_config INFO skipping workflows 
11:54:33,275 graphrag.index.run INFO Running pipeline
11:54:33,275 graphrag.index.storage.file_pipeline_storage INFO Creating file storage at output\20240715-115433\artifacts
11:54:33,279 graphrag.index.input.load_input INFO loading input from root_dir=input
11:54:33,280 graphrag.index.input.load_input INFO using file storage for input
11:54:33,285 graphrag.index.storage.file_pipeline_storage INFO search input for files matching .*\.txt$
11:54:33,287 graphrag.index.input.text INFO found text files from input, found [('breast_cancer.txt', {})]
11:54:33,301 graphrag.index.workflows.load INFO Workflow Run Order: ['create_base_text_units', 'create_base_extracted_entities', 'create_summarized_entities', 'create_base_entity_graph', 'create_final_entities', 'create_final_nodes', 'create_final_communities', 'join_text_units_to_entity_ids', 'create_final_relationships', 'join_text_units_to_relationship_ids', 'create_final_community_reports', 'create_final_text_units', 'create_base_documents', 'create_final_documents']
11:54:33,302 graphrag.index.run INFO Final # of rows loaded: 1
11:54:33,786 graphrag.index.run INFO Running workflow: create_base_text_units...
11:54:33,786 graphrag.index.run INFO dependencies for create_base_text_units: []
11:54:33,805 datashaper.workflow.workflow INFO executing verb orderby
11:54:33,817 datashaper.workflow.workflow INFO executing verb zip
11:54:33,829 datashaper.workflow.workflow INFO executing verb aggregate_override
11:54:33,851 datashaper.workflow.workflow INFO executing verb chunk
11:54:34,664 datashaper.workflow.workflow INFO executing verb select
11:54:34,683 datashaper.workflow.workflow INFO executing verb unroll
11:54:34,705 datashaper.workflow.workflow INFO executing verb rename
11:54:34,724 datashaper.workflow.workflow INFO executing verb genid
11:54:34,750 datashaper.workflow.workflow INFO executing verb unzip
11:54:34,770 datashaper.workflow.workflow INFO executing verb copy
11:54:34,788 datashaper.workflow.workflow INFO executing verb filter
11:54:34,835 graphrag.index.emit.parquet_table_emitter INFO emitting parquet table create_base_text_units.parquet
11:54:35,380 graphrag.index.run INFO Running workflow: create_base_extracted_entities...
11:54:35,381 graphrag.index.run INFO dependencies for create_base_extracted_entities: ['create_base_text_units']
11:54:35,382 graphrag.index.run INFO read table from storage: create_base_text_units.parquet
11:54:35,454 datashaper.workflow.workflow INFO executing verb entity_extract
11:54:35,499 graphrag.llm.openai.create_openai_client INFO Creating OpenAI client base_url=https://api.groq.com/openai/v1
11:54:35,530 graphrag.index.llm.load_llm INFO create TPM/RPM limiter for llama3-8b-8192: TPM=0, RPM=0
11:54:35,531 graphrag.index.llm.load_llm INFO create concurrency limiter for llama3-8b-8192: 5
11:54:36,644 datashaper.workflow.workflow INFO executing verb merge_graphs
11:54:37,36 graphrag.index.emit.parquet_table_emitter INFO emitting parquet table create_base_extracted_entities.parquet
11:54:37,557 graphrag.index.run INFO Running workflow: create_summarized_entities...
11:54:37,557 graphrag.index.run INFO dependencies for create_summarized_entities: ['create_base_extracted_entities']
11:54:37,558 graphrag.index.run INFO read table from storage: create_base_extracted_entities.parquet
11:54:37,715 datashaper.workflow.workflow INFO executing verb summarize_descriptions
11:54:41,147 graphrag.index.emit.parquet_table_emitter INFO emitting parquet table create_summarized_entities.parquet
11:54:41,664 graphrag.index.run INFO Running workflow: create_base_entity_graph...
11:54:41,665 graphrag.index.run INFO dependencies for create_base_entity_graph: ['create_summarized_entities']
11:54:41,666 graphrag.index.run INFO read table from storage: create_summarized_entities.parquet
11:54:41,756 datashaper.workflow.workflow INFO executing verb cluster_graph
11:54:43,41 datashaper.workflow.workflow INFO executing verb select
11:54:43,73 graphrag.index.emit.parquet_table_emitter INFO emitting parquet table create_base_entity_graph.parquet
11:54:43,657 graphrag.index.run INFO Running workflow: create_final_entities...
11:54:43,658 graphrag.index.run INFO dependencies for create_final_entities: ['create_base_entity_graph']
11:54:43,659 graphrag.index.run INFO read table from storage: create_base_entity_graph.parquet
11:54:43,759 datashaper.workflow.workflow INFO executing verb unpack_graph
11:54:44,382 datashaper.workflow.workflow INFO executing verb rename
11:54:44,419 datashaper.workflow.workflow INFO executing verb select
11:54:44,450 datashaper.workflow.workflow INFO executing verb dedupe
11:54:44,482 datashaper.workflow.workflow INFO executing verb rename
11:54:44,515 datashaper.workflow.workflow INFO executing verb filter
11:54:44,658 datashaper.workflow.workflow INFO executing verb text_split
11:54:44,734 datashaper.workflow.workflow INFO executing verb drop
11:54:44,769 datashaper.workflow.workflow INFO executing verb merge
11:54:45,468 datashaper.workflow.workflow INFO executing verb text_embed
11:54:45,516 graphrag.llm.openai.create_openai_client INFO Creating OpenAI client base_url=http://localhost:1234/v1
11:54:45,548 graphrag.index.llm.load_llm INFO create TPM/RPM limiter for nomic-ai/nomic-embed-text-v1.5-GGUF/nomic-embed-text-v1.5.Q2_K.gguf: TPM=0, RPM=0
11:54:45,548 graphrag.index.llm.load_llm INFO create concurrency limiter for nomic-ai/nomic-embed-text-v1.5-GGUF/nomic-embed-text-v1.5.Q2_K.gguf: 5
11:54:45,842 graphrag.index.verbs.text.embed.strategies.openai INFO embedding 969 inputs via 969 snippets using 61 batches. max_batch_size=16, max_tokens=8191
11:54:49,570 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:54:53,275 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:54:57,608 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:55:04,857 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:55:15,614 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:55:34,604 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:55:56,937 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:56:19,239 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:56:41,537 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:57:03,851 graphrag.index.reporting.file_workflow_callbacks INFO Error Invoking LLM details={'input': ['"ZAKS T":Here is a comprehensive summary of the data:\n\nZaks T is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"DESILVIO M":Here is a comprehensive summary of the data:\n\nDeSilvio M is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SALAZAR V":Here is a comprehensive summary of the data:\n\nSalazar V is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"SPECTOR N":Here is a comprehensive summary of the data:\n\nSPECTOR N is a researcher who has been involved in the GeparQuinto study and has also authored a study on neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.', '"G5":"G5 is a study evaluating the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"ALVAREZ RH":Here is a comprehensive summary of the data:\n\nALVAREZ RH is an author of research papers on inflammatory breast cancer. Specifically, Alvarez RH is an author of a study on the limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.', '"ENSOR J":"Ensor J is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"HUONG TLP":"Huong TLP is an author of a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"JOHNSTON S":"Johnston S is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"TRUDEAU M":"Trudeau M is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"KAUFMAN B":"Kaufman B is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"BLACKWELL K":"Blackwell K is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"LORUSSO P":"LoRusso P is an author of a study on predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."', '"J CLIN ONCOL CONF":"J Clin Oncol Conf is a conference that presented a study on limited efficacy and significant toxicities of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients."', '"PHASE II STUDY":"Phase II study is a type of clinical trial that evaluated the efficacy and safety of lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive inflammatory breast cancer patients.""Phase II study is a type of clinical trial that evaluated the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer."', '"PREDICTIVE BIOMARKER PROFILES":"Predictive biomarker profiles refer to the identification of biomarkers that can predict response to treatment targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer patients."']}
11:57:03,852 datashaper.workflow.workflow ERROR Error executing verb "text_embed" in create_final_entities: Connection error.
Traceback (most recent call last):
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_transports\default.py", line 69, in map_httpcore_exceptions
    yield
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_transports\default.py", line 373, in handle_async_request
    resp = await self._pool.handle_async_request(req)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection_pool.py", line 216, in handle_async_request
    raise exc from None
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection_pool.py", line 196, in handle_async_request
    response = await connection.handle_async_request(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection.py", line 99, in handle_async_request
    raise exc
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection.py", line 76, in handle_async_request
    stream = await self._connect(request)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection.py", line 122, in _connect
    stream = await self._network_backend.connect_tcp(**kwargs)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_backends\auto.py", line 30, in connect_tcp
    return await self._backend.connect_tcp(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_backends\anyio.py", line 114, in connect_tcp
    with map_exceptions(exc_map):
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\contextlib.py", line 155, in __exit__
    self.gen.throw(typ, value, traceback)
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_exceptions.py", line 14, in map_exceptions
    raise to_exc(exc) from exc
httpcore.ConnectError: All connection attempts failed

The above exception was the direct cause of the following exception:

Traceback (most recent call last):
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\_base_client.py", line 1558, in _request
    response = await self._client.send(
               ^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_client.py", line 1661, in send
    response = await self._send_handling_auth(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_client.py", line 1689, in _send_handling_auth
    response = await self._send_handling_redirects(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_client.py", line 1726, in _send_handling_redirects
    response = await self._send_single_request(request)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_client.py", line 1763, in _send_single_request
    response = await transport.handle_async_request(request)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_transports\default.py", line 372, in handle_async_request
    with map_httpcore_exceptions():
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\contextlib.py", line 155, in __exit__
    self.gen.throw(typ, value, traceback)
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_transports\default.py", line 86, in map_httpcore_exceptions
    raise mapped_exc(message) from exc
httpx.ConnectError: All connection attempts failed

The above exception was the direct cause of the following exception:

Traceback (most recent call last):
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\datashaper\workflow\workflow.py", line 415, in _execute_verb
    result = await result
             ^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\text_embed.py", line 105, in text_embed
    return await _text_embed_in_memory(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\text_embed.py", line 130, in _text_embed_in_memory
    result = await strategy_exec(texts, callbacks, cache, strategy_args)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\strategies\openai.py", line 61, in run
    embeddings = await _execute(llm, text_batches, ticker, semaphore)
                 ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\strategies\openai.py", line 105, in _execute
    results = await asyncio.gather(*futures)
              ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\asyncio\tasks.py", line 339, in __wakeup
    future.result()
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\asyncio\tasks.py", line 267, in __step
    result = coro.send(None)
             ^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\strategies\openai.py", line 99, in embed
    chunk_embeddings = await llm(chunk)
                       ^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\caching_llm.py", line 104, in __call__
    result = await self._delegate(input, **kwargs)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\rate_limiting_llm.py", line 177, in __call__
    result, start = await execute_with_retry()
                    ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\rate_limiting_llm.py", line 159, in execute_with_retry
    async for attempt in retryer:
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\tenacity\_asyncio.py", line 71, in __anext__
    do = self.iter(retry_state=self._retry_state)
         ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\tenacity\__init__.py", line 325, in iter
    raise retry_exc.reraise()
          ^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\tenacity\__init__.py", line 158, in reraise
    raise self.last_attempt.result()
          ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\concurrent\futures\_base.py", line 449, in result
    return self.__get_result()
           ^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\concurrent\futures\_base.py", line 401, in __get_result
    raise self._exception
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\rate_limiting_llm.py", line 165, in execute_with_retry
    return await do_attempt(), start
           ^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\rate_limiting_llm.py", line 147, in do_attempt
    return await self._delegate(input, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\base_llm.py", line 49, in __call__
    return await self._invoke(input, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\base_llm.py", line 53, in _invoke
    output = await self._execute_llm(input, **kwargs)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\openai\openai_embeddings_llm.py", line 36, in _execute_llm
    embedding = await self.client.embeddings.create(
                ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\resources\embeddings.py", line 215, in create
    return await self._post(
           ^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\_base_client.py", line 1826, in post
    return await self.request(cast_to, opts, stream=stream, stream_cls=stream_cls)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\_base_client.py", line 1519, in request
    return await self._request(
           ^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\_base_client.py", line 1592, in _request
    raise APIConnectionError(request=request) from err
openai.APIConnectionError: Connection error.
11:57:03,875 graphrag.index.reporting.file_workflow_callbacks INFO Error executing verb "text_embed" in create_final_entities: Connection error. details=None
11:57:03,909 graphrag.index.run ERROR error running workflow create_final_entities
Traceback (most recent call last):
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_transports\default.py", line 69, in map_httpcore_exceptions
    yield
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_transports\default.py", line 373, in handle_async_request
    resp = await self._pool.handle_async_request(req)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection_pool.py", line 216, in handle_async_request
    raise exc from None
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection_pool.py", line 196, in handle_async_request
    response = await connection.handle_async_request(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection.py", line 99, in handle_async_request
    raise exc
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection.py", line 76, in handle_async_request
    stream = await self._connect(request)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_async\connection.py", line 122, in _connect
    stream = await self._network_backend.connect_tcp(**kwargs)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_backends\auto.py", line 30, in connect_tcp
    return await self._backend.connect_tcp(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_backends\anyio.py", line 114, in connect_tcp
    with map_exceptions(exc_map):
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\contextlib.py", line 155, in __exit__
    self.gen.throw(typ, value, traceback)
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpcore\_exceptions.py", line 14, in map_exceptions
    raise to_exc(exc) from exc
httpcore.ConnectError: All connection attempts failed

The above exception was the direct cause of the following exception:

Traceback (most recent call last):
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\_base_client.py", line 1558, in _request
    response = await self._client.send(
               ^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_client.py", line 1661, in send
    response = await self._send_handling_auth(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_client.py", line 1689, in _send_handling_auth
    response = await self._send_handling_redirects(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_client.py", line 1726, in _send_handling_redirects
    response = await self._send_single_request(request)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_client.py", line 1763, in _send_single_request
    response = await transport.handle_async_request(request)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_transports\default.py", line 372, in handle_async_request
    with map_httpcore_exceptions():
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\contextlib.py", line 155, in __exit__
    self.gen.throw(typ, value, traceback)
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\httpx\_transports\default.py", line 86, in map_httpcore_exceptions
    raise mapped_exc(message) from exc
httpx.ConnectError: All connection attempts failed

The above exception was the direct cause of the following exception:

Traceback (most recent call last):
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\run.py", line 323, in run_pipeline
    result = await workflow.run(context, callbacks)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\datashaper\workflow\workflow.py", line 369, in run
    timing = await self._execute_verb(node, context, callbacks)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\datashaper\workflow\workflow.py", line 415, in _execute_verb
    result = await result
             ^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\text_embed.py", line 105, in text_embed
    return await _text_embed_in_memory(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\text_embed.py", line 130, in _text_embed_in_memory
    result = await strategy_exec(texts, callbacks, cache, strategy_args)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\strategies\openai.py", line 61, in run
    embeddings = await _execute(llm, text_batches, ticker, semaphore)
                 ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\strategies\openai.py", line 105, in _execute
    results = await asyncio.gather(*futures)
              ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\asyncio\tasks.py", line 339, in __wakeup
    future.result()
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\asyncio\tasks.py", line 267, in __step
    result = coro.send(None)
             ^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\index\verbs\text\embed\strategies\openai.py", line 99, in embed
    chunk_embeddings = await llm(chunk)
                       ^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\caching_llm.py", line 104, in __call__
    result = await self._delegate(input, **kwargs)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\rate_limiting_llm.py", line 177, in __call__
    result, start = await execute_with_retry()
                    ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\rate_limiting_llm.py", line 159, in execute_with_retry
    async for attempt in retryer:
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\tenacity\_asyncio.py", line 71, in __anext__
    do = self.iter(retry_state=self._retry_state)
         ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\tenacity\__init__.py", line 325, in iter
    raise retry_exc.reraise()
          ^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\tenacity\__init__.py", line 158, in reraise
    raise self.last_attempt.result()
          ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\concurrent\futures\_base.py", line 449, in result
    return self.__get_result()
           ^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\concurrent\futures\_base.py", line 401, in __get_result
    raise self._exception
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\rate_limiting_llm.py", line 165, in execute_with_retry
    return await do_attempt(), start
           ^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\rate_limiting_llm.py", line 147, in do_attempt
    return await self._delegate(input, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\base_llm.py", line 49, in __call__
    return await self._invoke(input, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\base\base_llm.py", line 53, in _invoke
    output = await self._execute_llm(input, **kwargs)
             ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\graphrag\llm\openai\openai_embeddings_llm.py", line 36, in _execute_llm
    embedding = await self.client.embeddings.create(
                ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\resources\embeddings.py", line 215, in create
    return await self._post(
           ^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\_base_client.py", line 1826, in post
    return await self.request(cast_to, opts, stream=stream, stream_cls=stream_cls)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\_base_client.py", line 1519, in request
    return await self._request(
           ^^^^^^^^^^^^^^^^^^^^
  File "C:\Users\Pesankar\AppData\Local\Programs\Python\Python311\Lib\site-packages\openai\_base_client.py", line 1592, in _request
    raise APIConnectionError(request=request) from err
openai.APIConnectionError: Connection error.
11:57:03,926 graphrag.index.reporting.file_workflow_callbacks INFO Error running pipeline! details=None
